Genetic susceptibility, elevated blood pressure and risk of atrial fibrillation

Genetic susceptibility, elevated blood pressure and risk of atrial fibrillation

Show other versions (1)

Bibliographic Details
Main Authors:	Nazarzadeh, M, Pinho-Gomes, A-C, Bidel, Z, Canoy, D, Dehghan, A, Byrne, KS, Bennett, DA, Smith, GD, Rahimi, K
Format:	Conference item
Language:	English
Published:	Lippincott, Williams & Wilkins 2021

Similar Items

Genetic susceptibility, elevated blood pressure and risk of atrial fibrillation
by: Nazarzadeh, M, et al.
Published: (2020)

Genetic susceptibility, elevated blood pressure, and risk of atrial fibrillation: a Mendelian randomization study
by: Milad Nazarzadeh, et al.
Published: (2021-03-01)

Genetic susceptibility, elevated blood pressure and risk of atrial fibrillation: a Mendelian randomization study
by: Nazarzadeh Larzjan, M, et al.
Published: (2021)

Blood pressure and risk of venous thromboembolism: a cohort analysis of 5.5 million UK adults and Mendelian randomization studies
by: Nazarzadeh, M, et al.
Published: (2022)

Blood pressure treatment: how low should you go? – Authors' reply
by: Rahimi, K, et al.
Published: (2021)

Blood pressure-lowering treatment for the prevention of cardiovascular events in patients with atrial fibrillation: an individual participant data meta-analysis
by: Pinho-Gomes, A-C, et al.
Published: (2021)

How much lowering of blood pressure is required to prevent cardiovascular disease in patients with and without previous cardiovascular disease?
by: Canoy, D, et al.
Published: (2022)

Effects of blood pressure-lowering drugs in heart failure: a systematic review and meta-analysis of randomized controlled trials
by: Pinho-Gomes, A, et al.
Published: (2019)

Management of blood pressure in atrial fibrillation, heart failure and multimorbidity
by: Pinho-Gomes, AC
Published: (2020)

Plasma lipids and risk of aortic valve stenosis: A Mendelian randomization study
by: Nazarzadeh, M, et al.
Published: (2020)

Systolic blood pressure and risk of valvular heart disease: a mendelian randomization study
by: Nazarzadeh, M, et al.
Published: (2019)

Systolic blood pressure and risk of valvular heart disease: A mendelian randomization study
by: Nazarzadeh, M, et al.
Published: (2019)

Blood pressure lowering and risk of new-onset type 2 diabetes: an individual participant data meta-analysis
by: Nazarzadeh Larzjan, M, et al.
Published: (2021)

Blood pressure-lowering treatment for the prevention of cardiovascular events in patients with atrial fibrillation: An individual participant data meta-analysis.
by: Ana-Catarina Pinho-Gomes, et al.
Published: (2021-06-01)

The Blood Pressure Lowering Treatment Trialists’ Collaboration: methodological clarifications of recent reports
by: Nazarzadeh, M, et al.
Published: (2022)

Remote dielectric sensing predicts elevated left atrial pressure in patients with atrial fibrillation
by: Shunsuke Tamaki, et al.
Published: (2024-08-01)

Elevated blood pressure, antihypertensive medications and bone health in the population: revisiting old hypotheses and exploring future research directions
by: Canoy, D, et al.
Published: (2021)

Investigating the stratified efficacy and safety of pharmacological blood pressure-lowering: an overall protocol for individual patient-level data meta-analyses of over 300 000 randomised participants in the new phase of the Blood Pressure Lowering Treatment Trialists’ Collaboration (BPLTTC)
by: Rahimi, K, et al.
Published: (2019)

Elevated β1-Adrenergic Receptor Autoantibody Levels Increase Atrial Fibrillation Susceptibility by Promoting Atrial Fibrosis
by: Luxiang Shang, et al.
Published: (2020-02-01)

Sodium-based paracetamol: impact on blood pressure, cardiovascular events, and all-cause mortality
by: Rao, S, et al.
Published: (2023)

Measurement of blood pressure in people with atrial fibrillation
by: Clark, CE, et al.
Published: (2019)

Long-term exposure to elevated systolic blood pressure in predicting incident cardiovascular disease: evidence from large-scale routine electronic health records
by: Solares, JR, et al.
Published: (2019)

Long‐Term Exposure to Elevated Systolic Blood Pressure in Predicting Incident Cardiovascular Disease: Evidence From Large‐Scale Routine Electronic Health Records
by: Jose Roberto Ayala Solares, et al.
Published: (2019-06-01)

Systolic blood pressure, chronic obstructive pulmonary disease and cardiovascular risk
by: Rao, S, et al.
Published: (2023)

Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis
by: Rahimi, K, et al.
Published: (2021)

Blood pressure modifies retinal susceptibility to intraocular pressure elevation.
by: Zheng He, et al.
Published: (2012-01-01)

Elevated plasma trimethyllysine is associated with incident atrial fibrillation
by: Mads M Svenningsson, et al.
Published: (2025-03-01)

Elevated liver enzymes associated with dronedarone for atrial fibrillation
by: Kelly R Ragucci
Published: (2013-11-01)

Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes: an individual participant-level data meta-analysis
by: Nazarzadeh, M, et al.
Published: (2022)

Systolic blood pressure and cardiovascular risk in patients with diabetes: a prospective cohort study
by: Rao, S, et al.
Published: (2022)

Atrial fibrillation and 24‐h ambulatory blood pressure pattern
by: Willem J. Verberk
Published: (2022-07-01)

Blood pressure control in anticoagulated patients with hypertension and atrial fibrillation
by: Vivencio Barrios, et al.
Published: (2017-09-01)

Screening for Atrial Fibrillation During Automatic Blood Pressure Measurements
by: Andrew Lowe, et al.
Published: (2018-01-01)

154 Myocardial nox2 activity regulates atrial fibrillation susceptibility
by: Mighiu, A, et al.
Published: (2017)

Blood pressure variability in hypertensive patients with atrial fibrillation in the VALUE trial
by: Maria H. Mehlum, et al.
Published: (2019-03-01)

Antihypertensive drug effects on long-term blood pressure: an individual-level data meta-analysis of randomised clinical trials
by: Canoy, D, et al.
Published: (2022)

Left Ventricular Diastolic Dysfunction with Elevated Filling Pressures Is Associated with Embolic Stroke of Undetermined Source and Atrial Fibrillation
by: Zubair Bashir, et al.
Published: (2024-10-01)

Isoproterenol Increases Left Atrial Fibrosis and Susceptibility to Atrial Fibrillation by Inducing Atrial Ischemic Infarction in Rats
by: Shiyu Ma, et al.
Published: (2020-04-01)

Intensive blood pressure lowering and risk of diabetes: Friend or foe?
by: Nazarzadeh, M, et al.
Published: (2019)

Increased Vulnerability to Atrial Fibrillation Is Associated With Increased Susceptibility to Alternans in Old Sheep
by: Charles M. Pearman, et al.
Published: (2018-12-01)